
|Articles|January 15, 2004
Inspire Pharmaceuticals to launch epinastine
Irvine, CA-Allergan Inc. and Inspire Pharmaceuticals Inc. will jointly promote epinastine HCl ophthalmic solution 0.05% (Elestat), with Inspire taking on primary duties for sales, promotion, and marketing.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses
3
Throwback Series: Managing bilateral diabetic macular edema early in practice
4
ICYMI: AAO 2025 showcases new technologies and continued research
5

















































.png)


